Governors Lane LP Cerevel Therapeutics Holdings, Inc. Transaction History

Governors Lane LP

  • $1.21 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.96 - $42.75 $7.51 Million - $8.24 Million
192,700 New
192,700 $7.88 Million
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $7.39 Million - $15.5 Million
364,400 New
364,400 $15.5 Million
Q2 2021

Aug 16, 2021
SELL
$12.56 - $29.69 $2.4 Million - $5.67 Million
-191,104 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$9.82 - $18.27 $1.88 Million - $3.49 Million
191,104 New
191,104 $3.17 Million

Others Institutions Holding CERE

# of Institutions
8
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Governors Lane LP Portfolio

Follow Governors Lane LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Governors Lane LP, based on Form 13F filings with the SEC.

News

Stay updated on Governors Lane LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email